HDAC9 and colorectal neoplasm: In addition to modulating immune responses and activating AMPK, SCFAs attenuate LPS-induced inflammation, inhibit colorectal tumor cell proliferation via HDAC inhibition in a concentration-dependent manner, and enhance gut barrier integrity by upregulating tight junction proteins [84,85].